Page 5 - Digestive Oncology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Digestive oncology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Digestive Oncology Today - Breaking & Trending Today

Pemazyre® approved for adults with cholangiocarcinoma in Europe

Pemazyre® approved for adults with cholangiocarcinoma in Europe
europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.

Region Flamande , Eric Van Cutsem , Incyte Pemazyre , European Medicines Agency , European Commission , University Hospitals Gasthuisberg , Committee For Medicinal Products Human Use , Division Head Of Digestive Oncology , University Of Leuven , Medicinal Products , Human Use , Chief Executive Officer , Division Head , Digestive Oncology , ஐரோப்பிய தரகு , குழு க்கு மருத்துவ ப்ராடக்ட்ஸ் மனிதன் பயன்பாடு , மருத்துவ ப்ராடக்ட்ஸ் , மனிதன் பயன்பாடு , தலைமை நிர்வாகி அதிகாரி , பிரிவு தலை , செரிமான புற்றுநோயியல் ,

Investegate |INVENTIVA Announcements | INVENTIVA: Inventiva announces collaboration on non-invasive biomarkers to identify patients responding to lanifibranor with regards to NASH resolution and fibrosis improvemen

University,
“
The need to develop reliable NASH biomarkers is both clear and urgent as the utility of liver biopsy, the only diagnostic approach currently available, is limited due to its invasive nature, poor patient acceptability and sampling variability. So we are very much looking
forward to working with Inventiva on lanifibranor, a drug candidate that has shown very promising results in the field of NASH. Given the efficacy shown by lanifibranor during the NATIVE Phase IIb trial and the promising biomarker dataset available, we are confident that we will be able to meet our objective to develop
one or several robust biomarkers or composite biomarker score ....

United States , Yannick Tetzlaff , Aude Lepreux , Pierre Broqua , Patricial Bank , Brunswick Group , Department Of Hepato , Anna Mae Diehl Lab Of Duke University , Faculty Of Medicine Angers University , Digestive Oncology At Angers University Hospital , Hangers University , Euronext Paris , Liver Meeting Digital Experience , Non Alcoholic Fatty Liver Disease , Professor Boursier , Digestive Oncology , Anna Mae Diehl Lab , Duke University , Breakthrough Therapy , Fast Track , Nasdaq Global Market , Roquet Montegon , Universal Registration Document , Des March , Interaction Fibrose , Fibrosis Interaction ,

INVENTIVA: Inventiva announces collaboration on non-invasive biomarkers to identify patients responding to lanifibranor with regards to NASH resolution and fibrosis improvemen

INVENTIVA: Inventiva announces collaboration on non-invasive biomarkers to identify patients responding to lanifibranor with regards to NASH resolution and fibrosis improvemen
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , Yannick Tetzlaff , Aude Lepreux , Pierre Broqua , Patricial Bank , Brunswick Group , Department Of Hepato , Anna Mae Diehl Lab Of Duke University , Faculty Of Medicine Angers University , Digestive Oncology At Angers University Hospital , Hangers University , Euronext Paris , Liver Meeting Digital Experience , Non Alcoholic Fatty Liver Disease , Professor Boursier , Digestive Oncology , Anna Mae Diehl Lab , Duke University , Breakthrough Therapy , Fast Track , Roquet Montegon , Universal Registration Document , Des March , Interaction Fibrose , Fibrosis Interaction , Hepatic Tumor ,

NOXXON Appoints Leading Pancreatic Cancer Experts to Scientific Advisory Board

Press release content from Business Wire. The AP news staff was not involved in its creation.
NOXXON Appoints Leading Pancreatic Cancer Experts to Scientific Advisory Board
February 8, 2021 GMT
Regulatory News:
NOXXON Pharma N.V.
(Euronext Growth Paris: ALNOX), a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME), announced today the appointment of four leading pancreatic cancer experts to its Scientific Advisory Board (SAB). Led by the newly appointed Chair, Dr. Jose Saro, the SAB will provide strategic and scientific counsel to NOXXON’s clinical programs in this indication.
“These prominent research leaders bring long-standing clinical expertise, cutting-edge scientific knowledge, and a track record of successfully developing new drugs to treat this devastating disease. They fully understand the challenges of developing new drugs for pancreas cancer where the tumor microenvironment plays a large ....

United States , France General , Ulf Jungnelius , Wissenschaftlichen Medizinischen Fachgesellschaften , Gabriela Chiorean , Arthur Rouill , Valeria Fisher , Aram Mangasarian , Pharmanv Euronext , Jose Saro , Weill Cornell Medical College , University Of Ulm , Davidm Rubenstein Center , Pancreatic Cancer Task , Innovative Cancer Research , German Cancer Society Deutschen Krebsgesellschaft , Cancer Research Network , Uw Medicine Fred Hutchinson Cancer Research Center , Seattle Cancer Care Alliance , Pancreatic Cancer Research Team , Clinical Research , Gastrointestinal Oncology Program , Honor Health Research Institute , Fred Hutchinson Cancer Research Center , European Society For Digestive Oncology , Certification Commission Of Visceral Oncology Centers ,